Stem Cell Therapeutics Acquires an Exclusive Option to License Prostate … – Marketwire (press release)
|
Stem Cell Therapeutics Acquires an Exclusive Option to License Prostate …
Marketwire (press release) “This agreement provides Stem Cell Therapeutics with an opportunity to evaluate several highly promising therapeutic targets, all of which are expressed on prostate cancer stem cells, as well as on other types of cancers,” added Dr. Bob Uger, SCT's … Gambling on human lifeThe Freeport News House panel trains sights on unregulated stem–cell therapy in PHInterAksyon Lab Burger …read more    |
